pRRL_SRSF2_P95H_mCherry Citations (3)
Originally described in: SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition.Kim E, Ilagan JO, Liang Y, Daubner GM, Lee SC, Ramakrishnan A, Li Y, Chung YR, Micol JB, Murphy ME, Cho H, Kim MK, Zebari AS, Aumann S, Park CY, Buonamici S, Smith PG, Deeg HJ, Lobry C, Aifantis I, Modis Y, Allain FH, Halene S, Bradley RK, Abdel-Wahab O Cancer Cell. 2015 May 11;27(5):617-30. doi: 10.1016/j.ccell.2015.04.006. PubMed Journal
Articles Citing pRRL_SRSF2_P95H_mCherry
Articles |
---|
GPATCH8 modulates mutant SF3B1 mis-splicing and pathogenicity in hematologic malignancies. Benbarche S, Pineda JMB, Galvis LB, Biswas J, Liu B, Wang E, Zhang Q, Hogg SJ, Lyttle K, Dahi A, Lewis AM, Sarchi M, Rahman J, Fox N, Ai Y, Mehta S, Garippa R, Ortiz-Pacheco J, Li Z, Monetti M, Stanley RF, Doulatov S, Bradley RK, Abdel-Wahab O. Mol Cell. 2024 May 16;84(10):1886-1903.e10. doi: 10.1016/j.molcel.2024.04.006. Epub 2024 Apr 29. PubMed |
A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignancies. Liu X, Devadiga SA, Stanley RF, Morrow R, Janssen K, Quesnel-Vallieres M, Pomp O, Moverley AA, Li C, Skuli N, Carroll MP, Huang J, Wallace DC, Lynch KW, Abdel-Wahab O, Klein PS. bioRxiv [Preprint]. 2024 Apr 23:2023.06.25.546449. doi: 10.1101/2023.06.25.546449. PubMed |
A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignancies. Liu X, Devadiga SA, Stanley RF, Morrow RM, Janssen KA, Quesnel-Vallieres M, Pomp O, Moverley AA, Li C, Skuli N, Carroll M, Huang J, Wallace DC, Lynch KW, Abdel-Wahab O, Klein PS. J Clin Invest. 2024 May 7;134(12):e175619. doi: 10.1172/JCI175619. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.